Advanced Diabetes Supply

Blog.

Diabetes Alert Day: Turning Awareness into Better Access and Better Outcomes

diabetes alert day

Diabetes Alert Day, observed annually on the fourth Tuesday of March, serves as a valuable moment for the healthcare community to pause and reflect on the progress made in managing one of the country’s most prevalent chronic conditions. With over 40 million Americans currently living with diabetes, the condition represents a significant portion of U.S. healthcare activity, accounting for one out of every four dollars spent on care.1


For health plans and payers, this day is less about a “warning” and more about an opportunity to refine benefit designs that support members in their daily journey, ensuring that the path to wellness is as seamless and cost-effective as possible.


Research published in the June 2024 Journal of Medical Internet Research Diabetes highlights a clear DME advantage. The study found that when members receive Continuous Glucose Monitors (CGMs) through Durable Medical Equipment providers rather than retail pharmacies, they see a 23% increase in adherence and a 35% reduction in average total healthcare costs.2


At Edgepark, Advanced Diabetes Supply, and US MED, our goal is to collaborate with payers to streamline and elevate the medical supply ordering and management process. Our collective footprint allows us to reach 94% of covered lives, focusing on reducing the administrative friction that can lead to gaps in care. By supporting both medical and pharmacy channels, we help ensure the transition to life-changing technology is seamless for patients and operationally efficient for the health plan.

This Diabetes Alert Day, we celebrate the innovations that make care more accessible and look forward to helping payers build even stronger, more coordinated care experiences for the millions of individuals they serve.

To learn more about the study, visit: Study: DME vs Pharmacy-Sourced CGMs Benefit Patients More.

  1. Economic Costs of Diabetes in the U.S. in 2022 | Diabetes Care | American Diabetes Association
  2. JMIR Diabetes – Exploring the Impact of Device Sourcing on Real-World Adherence and Cost Implications of Continuous Glucose Monitoring in Patients With Diabetes: Retrospective Claims Analysis